Santhera Pharmaceuticals Holding AG (SPHDF)
18.30
0.00 (0.00%)
USD |
OTCM |
Oct 15, 16:00
Santhera Pharmaceuticals SG&A Expense (TTM) : 18.92M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.92M |
| December 31, 2025 | 37.06M |
| June 30, 2025 | 38.30M |
| December 31, 2024 | 34.68M |
| June 30, 2024 | 35.26M |
| December 31, 2023 | 34.56M |
| June 30, 2023 | 26.64M |
| December 31, 2022 | 26.63M |
| June 30, 2022 | 28.75M |
| December 31, 2021 | 24.09M |
| June 30, 2021 | 20.05M |
| December 31, 2020 | 25.37M |
| June 30, 2020 | 35.18M |
| December 31, 2019 | 39.53M |
| June 30, 2019 | 38.29M |
| December 31, 2018 | 41.16M |
| June 30, 2018 | 46.51M |
| December 31, 2017 | 43.68M |
| June 30, 2017 | 35.47M |
| December 31, 2016 | 31.32M |
| June 30, 2016 | 27.05M |
| December 31, 2015 | 17.28M |
| Date | Value |
|---|---|
| June 30, 2015 | 7.900M |
| December 31, 2014 | 5.157M |
| June 30, 2014 | 3.529M |
| December 31, 2013 | 4.335M |
| June 30, 2013 | 5.495M |
| December 31, 2012 | 6.323M |
| June 30, 2012 | 10.58M |
| December 31, 2011 | 13.85M |
| June 30, 2011 | 13.27M |
| December 31, 2010 | 13.28M |
| June 30, 2010 | 23.38M |
| December 31, 2009 | 23.34M |
| June 30, 2009 | 19.73M |
| December 31, 2008 | 19.20M |
| June 30, 2008 | 23.02M |
| December 31, 2007 | 24.57M |
| June 30, 2007 | 17.84M |
| December 31, 2006 | 13.66M |
| June 30, 2006 | 8.466M |
| December 31, 2005 | 4.550M |
| June 30, 2005 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Basilea Pharmaceutica AG | 45.60M |
| BeOne Medicines Ltd. | 2.238B |
| AC Immune SA | 19.51M |
| CRISPR Therapeutics AG | 70.07M |
| Idorsia Ltd. | 264.55M |